264 related articles for article (PubMed ID: 20543139)
1. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.
Irish JM; Myklebust JH; Alizadeh AA; Houot R; Sharman JP; Czerwinski DK; Nolan GP; Levy R
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12747-54. PubMed ID: 20543139
[TBL] [Abstract][Full Text] [Related]
2. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.
Irish JM; Czerwinski DK; Nolan GP; Levy R
Blood; 2006 Nov; 108(9):3135-42. PubMed ID: 16835385
[TBL] [Abstract][Full Text] [Related]
3. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
[TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.
Haebe S; Shree T; Sathe A; Day G; Czerwinski DK; Grimes SM; Lee H; Binkley MS; Long SR; Martin B; Ji HP; Levy R
Blood; 2021 May; 137(21):2869-2880. PubMed ID: 33728464
[TBL] [Abstract][Full Text] [Related]
5. DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.
Amin R; Mourcin F; Uhel F; Pangault C; Ruminy P; Dupré L; Guirriec M; Marchand T; Fest T; Lamy T; Tarte K
Blood; 2015 Oct; 126(16):1911-20. PubMed ID: 26272216
[TBL] [Abstract][Full Text] [Related]
6. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
[TBL] [Abstract][Full Text] [Related]
7. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation.
Haxhinasto SA; Bishop GA
J Biol Chem; 2004 Jan; 279(4):2575-82. PubMed ID: 14604983
[TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
9. Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells.
Eray M; Postila V; Eeva J; Ripatti A; Karjalainen-Lindsberg ML; Knuutila S; Andersson LC; Pelkonen J
Scand J Immunol; 2003 Jun; 57(6):545-55. PubMed ID: 12791092
[TBL] [Abstract][Full Text] [Related]
10. Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment.
Chevalier N; Mueller M; Mougiakakos D; Ihorst G; Marks R; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016 Sep; 57(9):2150-60. PubMed ID: 26757600
[TBL] [Abstract][Full Text] [Related]
11. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
12. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system.
Johnson PW; Watt SM; Betts DR; Davies D; Jordan S; Norton AJ; Lister TA
Blood; 1993 Sep; 82(6):1848-57. PubMed ID: 7691240
[TBL] [Abstract][Full Text] [Related]
13. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
Araujo-Ayala F; Pérez-Galán P; Campo E
Hematol Oncol; 2021 Jun; 39 Suppl 1():83-87. PubMed ID: 34105816
[TBL] [Abstract][Full Text] [Related]
14. Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape.
Mourcin F; Verdière L; Roulois D; Amin R; Lamaison C; Sibut V; Thamphya B; Pangault C; Monvoisin C; Huet S; Seffals M; Baulande S; Mechta-Grigoriou F; Legoix P; Rossille D; Guirriec M; Léonard S; Cartron G; Salles G; Fest T; Tarte K
Immunity; 2021 Aug; 54(8):1788-1806.e7. PubMed ID: 34166622
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
Mizuno T; Rothstein TL
J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
[TBL] [Abstract][Full Text] [Related]
16. The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.
Sander B; de Jong D; Rosenwald A; Xie W; Balagué O; Calaminici M; Carreras J; Gaulard P; Gribben J; Hagenbeek A; Kersten MJ; Molina TJ; Lee A; Montes-Moreno S; Ott G; Raemaekers J; Salles G; Sehn L; Thorns C; Wahlin BE; Gascoyne RD; Weller E
Haematologica; 2014 Apr; 99(4):715-25. PubMed ID: 24510338
[TBL] [Abstract][Full Text] [Related]
17. Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients.
Nova-Lamperti E; Chana P; Mobillo P; Runglall M; Kamra Y; McGregor R; Lord GM; Lechler RI; Lombardi G; Hernandez-Fuentes MP;
Transplantation; 2017 Mar; 101(3):541-547. PubMed ID: 27472092
[TBL] [Abstract][Full Text] [Related]
18. Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro.
Schultze JL; Seamon MJ; Michalak S; Gribben JG; Nadler LM
Blood; 1997 May; 89(10):3806-16. PubMed ID: 9160688
[TBL] [Abstract][Full Text] [Related]
19. B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation.
Mizuno T; Rothstein TL
J Immunol; 2005 Mar; 174(6):3369-76. PubMed ID: 15749869
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.
Xie M; Jiang Q; Zhao S; Zhao J; Ye X; Qian W
Int Immunopharmacol; 2020 Aug; 85():106684. PubMed ID: 32540726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
